EdgarLookup

Bodhi Tree Biotechnology Inc — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bodhi Tree Biotechnology Inc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2026 Dec 31, 2025 $0 Feb 13, 2026
Q3 2025 Jun 30, 2025 $5.0K Aug 12, 2025
Q2 2025 Mar 31, 2025 $5.0K May 20, 2025
Q1 2026 Dec 31, 2024 $5.0K Feb 13, 2026
Q3 2025 Jun 30, 2024 $15.0K Aug 12, 2025

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2026 Dec 31, 2025 ($52.9K) Feb 13, 2026
Q3 2025 Jun 30, 2025 ($20.8K) Aug 12, 2025
Q2 2025 Mar 31, 2025 ($53.4K) May 20, 2025
Q1 2026 Dec 31, 2024 ($64.8K) Feb 13, 2026
Q3 2025 Jun 30, 2024 $9.7K Aug 12, 2025
Q2 2025 Mar 31, 2024 ($116) May 20, 2025

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q1 2026 Dec 31, 2025 ($52.9K) Feb 13, 2026
Q3 2025 Jun 30, 2025 ($20.0K) Aug 12, 2025
Q2 2025 Mar 31, 2025 ($52.2K) May 20, 2025
Q1 2026 Dec 31, 2024 ($64.8K) Feb 13, 2026
Q3 2025 Jun 30, 2024 $9.7K Aug 12, 2025
Q2 2025 Mar 31, 2024 ($116) May 20, 2025